Eating this kind of bread can raise colon cancer patients' risk of death
Eating white bread and other foods considered to be proinflammatory can raise colon cancer patients' risk of death from the disease, researchers said this week.
Of a study of more than 1,600 patients with stage III colon cancer, people who consumed the most of those foods — also including french fries, hot dogs, and soda — during a phase 3 clinical trial showed a shorter overall survival post-treatment compared to those on a proinflammatory diet. The patients who ate a proinflammatory diet had an 87 percent higher risk of death than those who consumed the least proinflammatory food.
Inflammation is the body's immune response to stimulus, such as falling down or burning your finger. Both too little and too much inflammation can cause problems, and most chronic diseases are believed to be rooted in inflammation that lasts over time. Some of the foods that can contribute to inflammation have been linked to cancer risk.
'One of the most common questions that patients ask is what they should do after treatment to maximally reduce their risk of cancer recurrence and improve survival,' Dr. Sara Char, a clinical fellow in hematology and oncology at Boston's Dana-Farber Cancer Institute, said in a statement. 'These findings add to the published literature about the importance of dietary patterns and physical activity in outcomes of patients with colorectal cancer.'
Char was the first author of the research which was presented on Sunday at this year's American Society of Clinical Oncology Annual Meeting.
'This study provides additional evidence that diet may be important for improving outcomes and survival in patients with stage III colon cancer,' co-author Dr. Kimmie Ng, also of Dana-Farber, said. 'Further studies are needed to tailor specific dietary recommendations for patients with colon cancer, and to understand the biological mechanisms underlying the relationship between proinflammatory diets and survival.'
The use of the anti-inflammatory drug in the participants' trial, which is known as celecoxib, did not have a significant influence on the relationship between diet and survival, but the authors also noted that those who engaged in higher levels of physical activity had the best overall survival outcomes.
Their findings come following previous research that showed systemic inflammation can increase the risk of colon cancer development and progression. Using anti-inflammatory drugs can reduce the risk of recurrence in selected patients with stage III colon cancer, the Dana-Farber researchers said. It remains unclear how much diet could affect cancer outcomes after treatment, but these findings add to a growing body of knowledge that could affect tens of thousands of Americans with colorectal cancer.
Some 150,000 people are diagnosed with colorectal cancer each year in the U.S. It is the second-most common cause of cancer deaths for men and women in the U.S., and is expected to cause about 52,900 deaths this year. The average five-year survival for patients with stage III colon cancer is around 80 percent, although between 25 and 35 percent of patients experience a recurrence of cancer during that time.
The researchers say that they plan to conduct more detailed investigations of the biological effects of diet and lifestyle on colon cancer outcomes, including those with metastatic colon cancer and those diagnosed at younger ages, under age 50.
The majority of Americans — as many as 57 percent — may be eating a diet that promotes inflammation, researchers at the Ohio State University found last year.
In 2018, a Harvard study found that people who ate foods that promoted inflammation had a higher rate of colorectal cancer compared with people who ate the least foods, with a 22 percent higher risk for men than women.
Eating white bread and drinking alcohol are linked to an increased risk for developing colorectal cancer. Whole grains have anti-cancer properties and eating fiber helps to reduce colorectal cancer risk, researchers told Fox News Digital in 2023. The next year, a study found potential risk for white bread intake.
Alternatively, consuming more dark leafy greens, vegetables, nuts, whole grains, and protein sources that are high in omega-3 fatty acids can help fight inflammation, according to UCLA Health. The Mediterranean diet may be the most beneficial, Johns Hopkins Medicine notes.
'I want to emphasize that people really need to focus on their pattern of eating — as opposed to eating a few particular foods — to reduce inflammation,' Dr. Edwin McDonald, a gastroenterologist at UChicago Medicine, wrote. ' There's no miracle food out there that's going to cure people with chronic inflammation. You need to have an anti-inflammatory lifestyle and diet.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Journals
an hour ago
- Business Journals
3 simple steps for employers to lower health care costs and ensure better employee care
It's no secret that the current health care system is unsustainable. Nearly half of Americans receive health care coverage through their employer and over the past two decades, employer-sponsored health care costs have risen by over 200%. Many businesses can no longer front the costs — and the burden is being shifted onto employees. The result? Health care has become unaffordable for many working Americans — for some employees cost shifting has made engaging care unaffordable and 40% of American adults are struggling with medical debt — a shockingly high number. Despite this astronomical rise in cost, most brokers and benefits consultants haven't changed the solutions they present to clients in decades. In our experience, only about 5-10% of brokers are offering their clients innovative alternatives and even fewer have fully embraced a different approach, leading to poor implementation and support when they do try something new. The reality is that health care operates as an inefficient market. Unlike most industries, higher costs do not necessarily equate to higher quality care — in fact, it can often be the opposite. We believe that by being proactive, transparent and strategic, employers can reverse this trend by reducing costs while ensuring their employees receive top-quality care. However, achieving transformational results demands a completely different approach. The four of us have spent years in this industry and have tailored a unique approach that enables us to achieve superior results. We've seen what works and what doesn't and the ineffective options continually peddled to employers. That's why we've joined forces to help employers to take control of their health care spend and save real money. Our approach We don't believe in a one-size-fits all health plans and we partner with HR leaders to bring their health care strategy to life while directly administering the change. This includes educating employees on what they need to know to make the most of their benefits. When you show people exactly how they can receive better care at a lower price, everyone wins. Our model is built on three pillars: education, pharmacy platform and Medicare Plus. Education: We empower members to navigate the health care system effectively and steer them towards high quality and cost-effective options. Navigating the health care system is hard and we take a hands-on approach, which helps members understand their choices and make informed decisions. This extra effort improves health outcomes while ensuring the best experience possible. According to publicly available data compiled by Image360, CT scans in Tampa, Florida, are typically billed between $4,500 and $9,700. Even after PPO discounts, health plan members and businesses still pay $2,200 to $4,800. The problem is, there's little transparency in pricing and high cost doesn't guarantee high quality. Imagine360 changes that. With Imagine360, the average cost for the same CT scan at the same facility drops to under $200. This translates to significant savings for the employee and the business. Pharmacy platform: Pharmacy spend is the fastest-growing expense when it comes to a health plan. Traditional solutions often lack transparency and instead function as profit centers. We craft innovative solutions to manage pharmacy costs, ensuring that members have access to affordable medications without compromising on quality. Medicare Plus: We provide a thoughtful alternative to conventional PPOs. This model offers robust coverage at significantly lower costs by anchoring reimbursements to fair, Medicare-based rates. The above approach collectively has proven to cut costs by nearly 25% on average. Through this approach, we've reduced the cost of health care so drastically that some clients now offer no-cost health care to all of their employees. At a time when most companies are forcing employees to pay upwards of thousands of dollars per month on health insurance premiums, our clients pick up the full cost of premiums for their employees. This difference is life-changing for many families. By adopting a three-pillar approach to health care benefits, these businesses have become highly sought-after employers in their communities. And it's not just beneficial for employees — it's advantageous for the health plan as well. When health care premiums are overpriced, only the highest utilizers enroll, which makes sense; you would only pay thousands of dollars a month in premiums if you anticipated high health care expenses. However, when coverage is affordable and well-structured, everyone participates, creating a healthier, more predictable and sustainable plan. If this sounds too good to be true, you're not alone. One employer came to us frustrated and skeptical. Every broker had pitched the same traditional solutions, none of which solved their problem. Their chief financial officer knew that if they could not control hospital claims costs, the business would be in trouble. We introduced Medicare Plus pricing as a strategic solution. We helped manage the learning curve for the first few months — but once leadership committed to the solution, the plan started working. Three years in, premiums, deductibles and copays have all dropped. Employees are getting better coverage, and the company has even added new benefits — while most of their peers are cutting back. Using an independent TPA Working with an independent third-party administrator (TPA) opens the door to a different and better playbook. Yes, it takes more work upfront — more education, communication, teamwork — but the payoff is worth it: a more flexible employee benefits solution that can lead to better care, lower costs, and long-term consistency. No more carrier swaps or yearly overhauls. We currently support 25 clients on this platform. With dedicated service teams, personalized enrollment education and long-term strategies, we help employers innovate — without impacting employee satisfaction. The result is a smoother, more positive experience. The road ahead We're all fighting the same fight: pushing back against a system that hides cost, limits choices, wastes money and is driving people to choose little or no coverage due to cost. But it doesn't have to be this way. With a three-pronged approach including employee education, pharmacy and Medicare Plus pricing, we're helping employers take back control of their health care costs. By putting people first and staying committed to value-based solutions, employers and brokers can finally break free from the old playbook — and build something better. McGriff is a Marsh & McLennan Agency LLC Company. Our solutions include commercial property and casualty, corporate bonding and surety, cyber, executive risk, management and professional liability, captives and alternative risk transfer programs, employee benefits, small business and personal lines insurance.
Yahoo
an hour ago
- Yahoo
Who are the eight new vaccine advisers appointed by Robert F Kennedy?
Robert F Kennedy Jr, the US health secretary, named eight new vaccine advisers this week to a critical Centers for Disease Control and Prevention (CDC) panel after firing all 17 experts who had held the roles. New members of the panel include experts who complained about being sidelined, a high-profile figure who has spread misinformation and medical professionals who appear to have little vaccine expertise. Kennedy made the announcement on social media. 'All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense,' Kennedy said in his announcement. 'They have each committed to demanding definitive safety and efficacy data before making any new vaccine recommendations.' Formally called the Advisory Committee on Immunization Practices (ACIP), the panel advises the CDC on how vaccines should be distributed. Those recommendations in effect determine the vaccines Americans can access. This week, Kennedy also removed the career officials typically tasked with vetting ACIP members and overseeing the advisory group, according to CBS News. Related: RFK Jr announces new panel of vaccine advisers after firing entire previous team Kennedy is a widely known vaccine skeptic who profited from suing vaccine manufacturers, has taken increasingly dramatic steps to upend US vaccine policy. 'ACIP is widely regarded as the international gold standard for vaccine decision-making,' said Helen Chu, one of the fired advisers, at a press conference with Patty Murray, a Democratic US senator. 'We cannot replace it with a process driven by one person's beliefs. In the absence of an independent, unbiased ACIP, we can no longer trust that safe and effective vaccines will be available to us and the people around us.' Arguably the most high-profile new member, Robert W Malone catapulted to stardom during the Covid-19 pandemic, appearing across rightwing media to criticize the Biden administration while describing himself as the inventor of mRNA technology. Messenger RNA technology powers the most widely used Covid-19 vaccines. While Malone was involved in very early experiments on the technology, researchers have said his role was limited. Malone's star rose quickly after appearing on the Joe Rogan podcast in 2022, where he and Rogan were criticized for spreading misinformation. On the show, Malone promoted the idea that both ivermectin and hydroxychloroquine could be possible treatments for Covid-19, but said research on the drugs was being suppressed. Ivermectin and hydroxychloroquine have not been shown to improve outcomes from Covid-19. 'Malone has a well-documented history of promoting conspiracy theories,' said Dr Jeffrey D Klausner, an epidemiologist and infectious disease expert at the University of Southern California, who recently told the New York Times he was in touch with Kennedy about his appointments. Kulldorff is a former Harvard professor of biostatistics and an infectious disease epidemiologist originally from Sweden. He said in an essay for the rightwing publication City Journal that he was fired because he refused to be vaccinated in line with the school policy. Like Malone, he rose to prominence during the pandemic as a 'Covid contrarian' who criticized the scientific consensus – views he said alienated him from his peers in the scientific community. He voiced his opposition to Covid-19 vaccine mandates and, in his essay, complained of being ignored by media and shadow-banned from Twitter. Kulldorff co-authored the Great Barrington Declaration, which called for limited closures instead of pandemic lockdowns before vaccines were available. The document became a touchstone for the American political right. Before the pandemic, Kulldorff studied vaccine safety and infectious disease, including co-authoring papers with members of CDC staff, such as on the Vaccine Safety Datalink. He was a member of the CDC's Covid Vaccine Safety Working Group in 2020, but said later he was fired because he disagreed with the agency's decision to pause Johnson & Johnson's Covid-19 vaccine and with Covid-19 vaccine mandates. He served on the Food and Drug Administration's (FDA) drug safety and risk management advisory committee around the same time. He has since enjoyed support from people already within the administration, including the Great Barrington Declaration co-author Dr Jay Bhattacharya, current head of the National Institutes of Health (NIH), and Dr Vinay Prasad, head of the Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research, which handles vaccines. Meissner is a professor of pediatrics at the Geisel School of Medicine at Dartmouth. He previously held advisory roles at the FDA and CDC, including ACIP from 2008-2012. In 2021, Meissner co-wrote an editorial with Dr Marty Makary, now the head of the FDA, which criticized mask mandates for children. In April, he was listed as an external adviser to ACIP on the respiratory syncytial virus (RSV) committee. Notably, Meissner is listed in a new conflicts of interest tool launched by the health department in March. Kennedy had criticized the fired ACIP members as 'plagued with persistent conflicts of interest'. 'He's a card-carrying infectious disease person who knows the burden of these diseases, and he knows the risk and the benefit,' Dr Kathryn Edwards told CBS News. Edwards previously served as chair of the FDA's vaccine advisory panel. Pebsworth is a nurse and the former consumer representative on the FDA's vaccine advisory committee. She is also the Pacific regional director for the National Association of Catholic Nurses, according to Kennedy's announcement. In 2020, Pebsworth spoke at the public comment portion of an FDA advisory panel meeting on Covid-19 vaccines. There, she identified herself as the volunteer research director for the National Vaccine Information Center (NVIC), 'and the mother of a child injured by his 15-month well-baby shots in 1998'. The NVIC is widely viewed as an anti-vaccine advocacy organization 'whose founder Barbara Lou Fisher must be considered a key figure of the anti-vaccine movement', according to an article from 2023 on how to counter anti-vaccine misinformation. Levi is a professor of operations management at the MIT Sloan School of Management who Kennedy described as an 'expert in healthcare analytics, risk management and vaccine safety'. In 2021, he opposed Covid-19 booster shot approval during the public comment portion of an FDA advisory committee hearing. In 2022, he wrote an article calling for EMS calls to be incorporated into vaccine safety data, arguing that cardiovascular side-effects could be undercounted – an article that later required correction. The potential effects of Covid-19 vaccines on heart health have been a focal point of right-leaning criticism. Last month, Levi was criticized for publishing a pre-print paper – a paper without peer review – that he co-authored with Dr Joseph Ladapo, the Florida surgeon general, a vaccine skeptic. The paper alleged that people who took the Pfizer Covid-19 vaccine were more likely to die than those who received the Moderna vaccine. Kennedy described Ross as 'a Clinical Professor of Obstetrics and Gynecology at George Washington University and Virginia Commonwealth University, with a career spanning clinical medicine, research, and public health policy'. However, as first reported by CBS News, Ross's name does not appear in faculty directories for either school. A spokesperson for George Washington University told the outlet that Ross did work as a clinical professor, but 'has not held a faculty appointment … since 2017'. A spokesperson for Virginia Commonwealth University described Ross as 'an affiliate faculty member' at a regional hospital system in the Capitol region. He is also listed as a partner at Havencrest Capital Management, as a board member of 'multiple private healthcare companies'. Hibbeln is a California-based psychiatrist who previously served as acting chief for the section of nutritional neurosciences at the NIH. He describes himself as an expert on omega-3, a fatty acid found in seafood. He also serves on the advisory council of a non-profit that advocates for Americans to eat more seafood. He practices at Barton Health, a hospital system in Lake Tahoe, California. His work influenced US public health guidelines on fish consumption during pregnancy. Pagano is an emergency medicine physician from Los Angeles 'with over 40 years of clinical experience', and a 'strong advocate for evidence-based medicine', according to Kennedy.
Yahoo
an hour ago
- Yahoo
Key RFK Jr advisers stand to profit from a new federal health initiative
Federal health officials are seeking to launch a 'bold, edgy' public service campaign to warn Americans of the dangers of ultra-processed foods in social media, transit ads, billboards and even text messages. And they potentially stand to profit off the results. Ultra-processed foods are a fixation for the US health and human services (HHS) secretary, Robert F Kennedy Jr, a vaccine skeptic who believes the US industrialized food supply is a 'primary culprit' behind many chronic diseases. 'We need to fix our food supply. And that's the number one thing,' Kennedy said at his confirmation hearing. Bringing healthier foods to Americans has proved to be one of the most resonant issues of Kennedy's 'Make America healthy again' (Maha) campaign – and arguably the only one that Democrats and Republicans agree on in principle. Kennedy has spent most of his tenure as health secretary dismantling key components of US vaccine infrastructure, instituting mass firings and defunding chronic disease prevention programs, such as for tobacco use. The secretary has been less successful in reigning in food makers. Food advocates have described voluntary changes between the government and manufacturers 'disappointing'. Kennedy was criticized by congressional Republicans for targeting agricultural pesticides in the 'Maha' report before it was even released – showing the limits of Republicans appetite for regulation, then the report itself was riddled with errors, likely generated by AI. 'The campaign's creative content will turn heads, create viral moments on social media, and – above all else – inspire Americans to take back their health through eating real food,' said a document published by the federal government that described the campaign. The campaign is expected to cost between $10m to $20m, according to documents. Anyone seeking to apply for the award will have a quick turnaround – the deadline is 26 June. 'The purpose of this requirement is to alert Americans to the role of processed foods in fueling the diabetes epidemic and other chronic diseases, inspire people to take personal responsibility for their diets, and drive measurable improvements in diabetes prevention and national health outcomes,' it continued. The new public relations campaign also highlights the Trump administration's unconventional approach to hiring – including its reliance on special government employees. A key adviser to Kennedy, Calley Means, could directly benefit from one of the campaign's stated aims: popularizing 'technology like wearables as cool, modern tools for measuring diet impact and taking control of your own health'. Calley Means is a senior Kennedy adviser, and was hired as a special government employee to focus on food policy, according to Bloomberg. He founded a company that helps Americans get such wearable devices reimbursed tax-free through health savings accounts. Casey Means is Calley's sister. She also runs a healthcare start-up, although hers sells wearable devices such as continuous glucose monitors. She is Kennedy's nominee for US surgeon general, and a healthcare entrepreneur whose business sells continuous glucose monitors – one such wearable device. Calley Means's company also works with Casey's company. Due to Calley Means's status as a special employee, he has not been forced to divest from his private business interests – a situation that has already resulted in an ethics complaint. Consumer advocates, such as the non-profit group Public Citizen, had warned such hiring practices could cause conflicts of interest. HHS did not respond to a request for comment about Calley Means's private business interests, or his role in crafting the publicity campaign. Although the publicity campaign focuses on the ultra-processed foods connection to diabetes, at least one high profile nutritionist was queasy about its focus. 'The ultra-processed foods – some of those include breakfast cereals that are ultra-processed because they are fortified with vitamins,' said Walter Willett, a professor of epidemiology and nutrition at the Harvard TH Chan School of Public Health. 'Those are good if they're whole grain breakfast cereals and whole grain breads,' he said. Ultra-processed foods are generally recognized as sodas, salty snacks and frozen meals engineered to be shelf-stable, convenient and inexpensive. Such foods are associated with increased risk of type 2 diabetes – or insulin resistance. The mechanism by which such foods could increase risk of diabetes is unknown, a problem that extends in part from the 'heterogeneous category' of foods that the ultra-processed category encompasses. The publicity campaign proposal does not venture into defining the category, even as Kennedy has fixated on it 'poisoning the American people'. 'When you say processed foods you don't envision a Coke in your brain, and that's the biggest problem,' said Willett, who added that most public service campaigns are carefully crafted and tested for effectiveness.
